# Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

> **NCT02630537** · — · COMPLETED · sponsor: **Lophius Biosciences GmbH** · enrollment: 133 (actual)

## Conditions studied

- Renal Failure Chronic Requiring Dialysis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02630537
- **Lead sponsor:** Lophius Biosciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02630537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02630537, "Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02630537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*